Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination Alzheimer therapy using anti-N3pGlu Abeta antibodies + a BACE inhibitor

Combination Alzheimer therapy using anti-N3pGlu Abeta antibodies + a BACE inhibitor

US Patent 9999624 · Granted Jun 19, 2018

Estimated economic value: $333,354,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stretchable sleeve cover for targets of different sizes2024
1,4-Oxazines useful as selective BACE1 inhibitors2019
BACE inhibitors2016
BACE inhibitors2015
BACE inhibitors2015
Tetrahydropyrrolothiazine compounds2015
Tetrahydropyrrolothiazine compounds2014
Tetrahydropyrrolothiazine compounds2014
Tetrahydropyrrolothiazine compounds2014
Tetrahydropyrrolothiazine compounds2014
BACE inhibitors2012
BACE inhibitors2010